International Agency for Research on Cancer (IARC) shared a post on LinkedIn:
“What does it take for cancer science to become national action?
How does IARC’s science move beyond publication and citation to shape real decisions, real systems, and real outcomes at national level?
Four pathways through which international cancer evidence becomes action – now being presented at IARC60.
And published ahead of this session, IARC has documented how its work supports public health impact across its 30 Participating States through the IARC Impact in Practice series. A new Viewpoint published in The Lancet Public Health brings these insights together, highlighting the often-hidden infrastructure behind impact: trusted assessments, robust data, sustained technical cooperation, and shared governance.
As IARC marks its 60th anniversary, in a context of rising cancer burden and increasing pressure on global health financing, the question is urgent: how can we sustain the shared science that helps countries act?
IARC Impact in Practice: from global cancer science to national action
Countries interested in shaping global cancer science
Global health funders and partners
Not in one of these groups? Help us extend the impact: share this with your network.”
Title: The International Agency for Research on Cancer: from global evidence to national action
Authors: Anna Schmütz, Véronique Chajàs, Clément Chauvet, Dorothy Keefe, Elisabete Weiderpass
Other articles about IARC on OncoDaily.
